Conversion Surgery After Administration of a <scp>TRK</scp> Inhibitor for Unresectable Parotid Gland Secretory Carcinoma
Conversion surgery and TRK inhibitor use were effective against unresectable parotid gland carcinoma with the NTRK fusion gene. The case provides a reference for conversion surgery use for unresectable parotid gland carcinomas.
Authors
- Koji Tsukamoto
- Sekai Kikuchi
- Yuichiro Tada (ORCID: https://orcid.org/0000-0002-0159-8660)
- Sho Iwaki (ORCID: https://orcid.org/0000-0003-1808-6941)
- Hiroshi Tsuge
- Shinichi Iwasaki (ORCID: https://orcid.org/0000-0002-1415-8701)
- Satsuki Nakano
- Takuma Matoba (ORCID: https://orcid.org/0000-0002-2043-678X)
- Kiyoshi Minohara
- A. Nagano (ORCID: https://orcid.org/0000-0002-2354-660X)
- Daisuke Kawakita (ORCID: https://orcid.org/0000-0003-3794-2790)
- Takayuki Murase (ORCID: https://orcid.org/0009-0003-3316-0000)
Institutions
- Nagoya City University (JP)
- Mita Hospital (JP)
Publication Details
- Journal
- Head & Neck
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1002/hed.28196
- Citations
- 1
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Japan Society for the Promotion of Science